Hofbauer LC - Search Results

1

Selective inhibition of receptor activator of NF-κB ligand (RANKL) in hematopoietic cells improves outcome after experimental myocardial infarction.

Slavic S, Andrukhova O, Ford K, Handschuh S, Latic N, Reichart U, Sasgary S, Bergow C, Hofbauer LC, Kostenuik PJ, Erben RG. Slavic S, et al. Among authors: hofbauer lc. J Mol Med (Berl). 2018 Jun;96(6):559-573. doi: 10.1007/s00109-018-1641-x. Epub 2018 May 8. J Mol Med (Berl). 2018. PMID: 29736604 Free PMC article.

2

Osteoprotegerin, RANK, and RANK ligand: the good, the bad, and the ugly in rheumatoid arthritis.

Hofbauer LC, Heufelder AE, Erben RG. Hofbauer LC, et al. J Rheumatol. 2001 Apr;28(4):685-7. J Rheumatol. 2001. PMID: 11327234 Review. No abstract available.

3

Role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in bone cell biology.

Hofbauer LC, Heufelder AE. Hofbauer LC, et al. J Mol Med (Berl). 2001 Jun;79(5-6):243-53. doi: 10.1007/s001090100226. J Mol Med (Berl). 2001. PMID: 11485016 Review.

4

Skeletal effects of cyclosporin A are gender related in rats.

Erben RG, Brunner KS, Breig B, Eberle J, Goldberg M, Hofbauer LC. Erben RG, et al. Among authors: hofbauer lc. Endocrinology. 2003 Jan;144(1):40-9. doi: 10.1210/en.2002-220513. Endocrinology. 2003. PMID: 12488328

5

Fatal attraction: why breast cancer cells home to bone.

Hofbauer LC, Rachner T, Singh SK. Hofbauer LC, et al. Breast Cancer Res. 2008;10(1):101. doi: 10.1186/bcr1848. Epub 2008 Jan 25. Breast Cancer Res. 2008. PMID: 18226190 Free PMC article.

6

Prevention of glucocorticoid-induced bone loss in mice by inhibition of RANKL.

Hofbauer LC, Zeitz U, Schoppet M, Skalicky M, Schüler C, Stolina M, Kostenuik PJ, Erben RG. Hofbauer LC, et al. Arthritis Rheum. 2009 May;60(5):1427-37. doi: 10.1002/art.24445. Arthritis Rheum. 2009. PMID: 19404943 Free article.

7

Orchiectomy upregulates free soluble RANKL in bone marrow of aged rats.

Proell V, Xu H, Schüler C, Weber K, Hofbauer LC, Erben RG. Proell V, et al. Among authors: hofbauer lc. Bone. 2009 Oct;45(4):677-81. doi: 10.1016/j.bone.2009.05.024. Epub 2009 Jun 6. Bone. 2009. PMID: 19501680

8

Inhibition of receptor activator of NF-kappaB ligand by denosumab attenuates vascular calcium deposition in mice.

Helas S, Goettsch C, Schoppet M, Zeitz U, Hempel U, Morawietz H, Kostenuik PJ, Erben RG, Hofbauer LC. Helas S, et al. Among authors: hofbauer lc. Am J Pathol. 2009 Aug;175(2):473-8. doi: 10.2353/ajpath.2009.080957. Epub 2009 Jul 9. Am J Pathol. 2009. PMID: 19590040 Free PMC article.

9

Regulation of bone mass and osteoclast function depend on the F-actin modulator SWAP-70.

Garbe AI, Roscher A, Schüler C, Lutter AH, Glösmann M, Bernhardt R, Chopin M, Hempel U, Hofbauer LC, Rammelt S, Egerbacher M, Erben RG, Jessberger R. Garbe AI, et al. Among authors: hofbauer lc. J Bone Miner Res. 2012 Oct;27(10):2085-96. doi: 10.1002/jbmr.1670. J Bone Miner Res. 2012. PMID: 22648978 Free article.

10

The promotion of osteoclastogenesis by sulfated hyaluronan through interference with osteoprotegerin and receptor activator of NF-κB ligand/osteoprotegerin complex formation.

Salbach-Hirsch J, Kraemer J, Rauner M, Samsonov SA, Pisabarro MT, Moeller S, Schnabelrauch M, Scharnweber D, Hofbauer LC, Hintze V. Salbach-Hirsch J, et al. Among authors: hofbauer lc. Biomaterials. 2013 Oct;34(31):7653-61. doi: 10.1016/j.biomaterials.2013.06.053. Epub 2013 Jul 17. Biomaterials. 2013. PMID: 23871544

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

450 results

Search Page

Filters